Methods and cellular structures
US-2024209323-A1 · Jun 27, 2024 · US
US9534201B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9534201-B2 |
| Application number | US-60578109-A |
| Country | US |
| Kind code | B2 |
| Filing date | Oct 26, 2009 |
| Priority date | Apr 26, 2007 |
| Publication date | Jan 3, 2017 |
| Grant date | Jan 3, 2017 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention provides a new readily accessible source of adult somatic stem cells from the gastrointestinal tract in general and oral mucosa in particular, methods for isolating pluripotent stem cells from oral mucosa, cells derived therefrom and uses thereof.
Opening claim text (preview).
What is claimed is: 1. A culture comprising pluripotent stem cells that originated in the lamina propria of the oral mucosa, in an in vitro culture medium that ensures growth in vitro without production of differentiated progeny cells at the expense of the pluripotent stem cells, wherein said stem cells each display all of the markers Nestin, p75, Sox2, Oct4 and Nanog. 2. The culture of claim 1 , wherein said culture medium is a low glucose medium. 3. The culture of claim 2 , wherein said low glucose medium is supplemented with 1-20% fetal calf serum and an antibiotic solution. 4. The culture of claim 1 , wherein said stem cells originated in the lamina propria of the gingival oral mucosa. 5. The culture of claim 1 , wherein said stem cells further express a plurality of the markers β-III tubulin, glial fibrillar acid protein (GFAP), 04, Tra-1-61, Tral-81, SSEA1-4, Rex1, ABCG2, hTert, Bmil, CD29, CD44, CD73, CD90, CD105, CD106, CD117, CD146, CD166 and Strol+. 6. The culture of claim 1 , wherein said stem cells express the histocompatibility marker HLA-ABC. 7. The culture of claim 1 , wherein said stem cells constitutively express said markers when cultured in a low glucose medium supplemented with 10% serum and an antibiotic solution. 8. A pluripotent stem cell that originated in the lamina propria of the oral mucosa which displays all of the markers Nestin, p75, Sox2, Oct4 and Nanog, and which stem cell further includes a foreign gene that has been inserted into the stem cell by genetic manipulation.
Cells of the oral mucosa · CPC title
Non-embryonic pluripotent stem cells, e.g. MASC (induced pluripotent stem cells C12N5/0696) · CPC title
Stomach; Intestine; Goblet cells; Oral mucosa; Saliva · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.